Edgestream Partners, L.P. Novavax Inc Transaction History
Edgestream Partners, L.P.
- $2.23 Billion
- Q3 2024
A detailed history of Edgestream Partners, L.P. transactions in Novavax Inc stock. As of the latest transaction made, Edgestream Partners, L.P. holds 125,114 shares of NVAX stock, worth $1.15 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
125,114Holding current value
$1.15 Million% of portfolio
0.07%Shares
5 transactions
Others Institutions Holding NVAX
# of Institutions
290Shares Held
94.7MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$109 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$103 Million35.54% of portfolio
-
State Street Corp Boston, MA7.69MShares$70.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$54.7 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $721M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...